National Institute of Nursing Research; Notice of Meeting, 46259-46260 [2021-17744]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 157 / Wednesday, August 18, 2021 / Notices
global disease burden is hampered by
remarkably high treatment costs and a
high number of undiagnosed infections.
Moreover, a significant number of
patients develop resistance and
additional treatment modalities may be
needed to dramatically reduce the
worldwide incidence of HCV infection.
The subject cell line may be a useful
tool for studying the mechanism of HCV
cellular entry and replication and could
be incorporated into an in vitro assay to
measure the effectiveness of novel HCV
targeted therapies or as a system for
improved propagation of HCV in
culture.
By overexpressing TACSTD2 in
Huh7.5 cells, scientists at the National
Institute of Allergy and Infectious
Diseases (NIAID) discovered that they
could restore the cellular localization of
two host cell HCV-entry factors that
become dysregulated in hepatocellular
carcinoma (HCC) cells. Overexpression
of TACSTD2 makes Huh7.5 cells more
broadly permissive to infection and
replication by multiple HCV genotypes
in comparison to the canonical Huh7.5
cell model. HCV does not replicate in
malignant HCC cells, possibly caused in
part by downregulation of TACSTD2
expression.
This technology is available for
licensing for commercial development
in accordance with 35 U.S.C. 209 and 37
CFR part 404.
Potential Commercial Applications
• Cell line to study hepatitis C virus
infection and replication or propagate
HCV in culture.
• Cell line to study cancer.
jbell on DSKJLSW7X2PROD with NOTICES
Development Stage
• Material.
Inventors: Patrizia Farci and Vandana
Sekhar (NIAID).
Publication: Sekhar V, Pollicino T,
Diaz G, Engle RE, Alayli F, Melis M,
Kabat J, Tice A, Pomerenke A, AltanBonnet N, Zamboni F, Lusso P, Emerson
SU, and Farci P. (2018) Infection with
hepatitis C virus depends on TACSTD2,
a regulator of claudin-1 and occludin
highly downregulated in hepatocellular
carcinoma. PLoS Pathog 14: e1006916.
doi: 10.1371/journal.ppat.1006916.
Licensing Contact: To license this
technology, please contact Elizabeth
Pitts, Ph.D., 240–669–5299;
elizabeth.pitts@nih.gov, and reference
E–040–2020.
Dated: August 12, 2021.
Surekha Vathyam,
Deputy Director, Technology Transfer and
Intellectual Property Office, National Institute
of Allergy and Infectious Diseases.
[FR Doc. 2021–17687 Filed 8–17–21; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
17:34 Aug 17, 2021
Jkt 253001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Cancer
Advisory Board.
The meeting will be held as a virtual
meeting and is open to the public as
indicated below. Individuals who plan
to view the virtual meeting and need
special assistance or other reasonable
accommodations to view the meeting
should notify the Contact Person listed
below in advance of the meeting. The
meeting will be videocast and can be
accessed from the NIH Videocasting and
Podcasting website (https://
videocast.nih.gov/).
A portion of the National Cancer
Advisory Board meeting will be closed
to the public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Advisory Board.
Date: August 31, 2021.
Open: 1:00 p.m. to 3:10 p.m.
Agenda: NCAB Subcommittee Meetings—
Subcommittee on Planning and Budget and
Ad Hoc Subcommittee on Global Cancer
Research.
Place: National Cancer Institute—Shady
Grove, 9609 Medical Center Drive, Rockville,
MD 20850 (Virtual Meeting).
Name of Committee: National Cancer
Advisory Board.
Date: September 1, 2021.
Open: 1:00 p.m. to 4:15 p.m.
Agenda: Director’s and Program reports
and presentations; business of the Board.
Closed: 4:25 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute—Shady
Grove, 9609 Medical Center Drive, Rockville,
MD 20850 (Virtual Meeting).
Contact Person: Paulette S. Gray, Ph.D.,
Director, Division of Extramural Activities,
National Cancer Institute—Shady Grove,
National Institutes of Health, 9609 Medical
Center Drive, 7th Floor, Room 7W444,
Bethesda, MD 20892, 240–276–6340, grayp@
mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
46259
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: NCAB:
https://deainfo.nci.nih.gov/advisory/ncab/
ncabmeetings.htm, where an agenda and any
additional information for the meetings will
be posted when available.
This notice is being published less than 15
days prior to the meeting due to scheduling
difficulties.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: August 13, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–17742 Filed 8–17–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Nursing Research;
Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Council for Nursing Research.
The meeting will be open to the
public as indicated below via videocast.
The URL link to this meeting is https://
videocast.nih.gov/watch=42425.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council for Nursing Research.
Date: September 14, 2021.
Open: 11:00 a.m. to 3:30 p.m.
E:\FR\FM\18AUN1.SGM
18AUN1
46260
Federal Register / Vol. 86, No. 157 / Wednesday, August 18, 2021 / Notices
Agenda: Discussion of Program Policies
and Issues.
Place: National Institutes of Health,
Building 31, 9000 Rockville Pike, Bethesda,
MD 20892 (Virtual Meeting).
Closed: 3:30 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 9000 Rockville Pike, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Susan E. Old, Ph.D.,
Acting Director, Division of Extramural
Science Programs, National Institutes of
Health, NINR, Bethesda, MD 20892–9824,
(301) 496–7291, oldse@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.ninr.nih.gov/aboutninr/nacnr where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.361, Nursing Research,
National Institutes of Health, HHS)
Dated: August 13, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–17744 Filed 8–17–21; 8:45 am]
BILLING CODE 4140–01–P
burden (i.e., the time, effort, and
resources used by the respondents to
respond), the estimated cost to the
respondent, and the actual information
collection instruments.
DATES: Comments are encouraged and
will be accepted for 60 days until
October 18, 2021.
ADDRESSES: All submissions received
must include the OMB Control Number
1615–NEW in the body of the letter, the
agency name and Docket ID USCIS–
2021–0017. Submit comments via the
Federal eRulemaking Portal website at
https://www.regulations.gov under eDocket ID number USCIS–2021–0017.
FOR FURTHER INFORMATION CONTACT:
USCIS, Office of Policy and Strategy,
Regulatory Coordination Division,
Samantha Deshommes, Chief, telephone
number (240) 721–3000 (This is not a
toll-free number. Comments are not
accepted via telephone message). Please
note contact information provided here
is solely for questions regarding this
notice. It is not for individual case
status inquiries. Applicants seeking
information about the status of their
individual cases can check Case Status
Online, available at the USCIS website
at https://www.uscis.gov, or call the
USCIS Contact Center at 800–375–5283
(TTY 800–767–1833).
SUPPLEMENTARY INFORMATION:
Comments
DEPARTMENT OF HOMELAND
SECURITY
U.S. Citizenship and Immigration
Services
[OMB Control Number 1615–NEW]
Agency Information Collection
Activities; New Collection: Petition for
Nonimmigrant Worker: H–2A
Classification and Petition for
Nonimmigrant Worker: H–2B
Classification
U.S. Citizenship and
Immigration Services, Department of
Homeland Security.
ACTION: 60-Day notice.
AGENCY:
The Department of Homeland
Security (DHS), U.S. Citizenship and
Immigration Services (USCIS) invites
the general public and other Federal
agencies to comment upon this
proposed new collection of information.
In accordance with the Paperwork
Reduction Act (PRA) of 1995, the
information collection notice is
published in the Federal Register to
obtain comments regarding the nature of
the information collection, the
categories of respondents, the estimated
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:34 Aug 17, 2021
Jkt 253001
USCIS is separating Form I–129,
Petition for Nonimmigrant Worker,
(OMB control number 1615–0009) into
several individual forms. These new
forms will combine information from
the main Form I–129 with information
from the current Supplements to create
unique forms tailored to specific
nonimmigrant classifications. USCIS
believes separating the current Form I–
129 into several individual forms will
consolidate and simplify the
information collection requirements for
respondents.
USCIS is creating Form I–129H2A,
Petition for Nonimmigrant Worker: H–
2A Classification, and Form I–129H2B,
Petition for Nonimmigrant Worker: H–
2B Classification.
Form I–129H2A will collect
information for the H–2A nonimmigrant
program. The H–2A program allows
U.S. employers or U.S. agents who meet
specific regulatory requirements to bring
noncitizens to the United States to fill
temporary agricultural jobs.
Form I–129H2B will collect
information for the H–2B nonimmigrant
program. The H–2B program allows U.S.
employers or U.S. agents who meet
specific regulatory requirements to bring
PO 00000
Frm 00087
Fmt 4703
Sfmt 4703
noncitizens to the United States to fill
temporary nonagricultural jobs.
USCIS will request approval of Form
I–129H2A and Form I–129H2B from
OMB as a new information collection.
USCIS previously submitted these forms
to OMB for approval during the 2020
USCIS Fee Rule; however, this rule was
enjoined and therefore the approval is
not in effect. USCIS has determined that
the creation of this new information
collection does not require rulemaking
and is therefore proceeding to seek
public comments on Form I–129H2A
and Form I–129H2B via a notice of
information collection published in the
Federal Register in accordance with the
Paperwork Reduction Act, 44 U.S.C.
3501–3521.
You may access the information
collection instrument with instructions
or additional information by visiting the
Federal eRulemaking Portal site at:
https://www.regulations.gov and
entering USCIS–2021–0017 in the
search box. All submissions will be
posted, without change, to the Federal
eRulemaking Portal at https://
www.regulations.gov, and will include
any personal information you provide.
Therefore, submitting this information
makes it public. You may wish to
consider limiting the amount of
personal information that you provide
in any voluntary submission you make
to DHS. DHS may withhold information
provided in comments from public
viewing that it determines may impact
the privacy of an individual or is
offensive. For additional information,
please read the Privacy Act notice that
is available via the link in the footer of
https://www.regulations.gov.
Written comments and suggestions
from the public and affected agencies
should address one or more of the
following four points:
(1) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(2) Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
(4) Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
E:\FR\FM\18AUN1.SGM
18AUN1
]]>Agencies
[Federal Register Volume 86, Number 157 (Wednesday, August 18, 2021)]
[Notices]
[Pages 46259-46260]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-17744]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Nursing Research; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Advisory
Council for Nursing Research.
The meeting will be open to the public as indicated below via
videocast. The URL link to this meeting is https://videocast.nih.gov/watch=42425. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council for Nursing
Research.
Date: September 14, 2021.
Open: 11:00 a.m. to 3:30 p.m.
[[Page 46260]]
Agenda: Discussion of Program Policies and Issues.
Place: National Institutes of Health, Building 31, 9000
Rockville Pike, Bethesda, MD 20892 (Virtual Meeting).
Closed: 3:30 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 9000
Rockville Pike, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Susan E. Old, Ph.D., Acting Director, Division
of Extramural Science Programs, National Institutes of Health, NINR,
Bethesda, MD 20892-9824, (301) 496-7291, [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: https://www.ninr.nih.gov/aboutninr/nacnr where an agenda and
any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.361,
Nursing Research, National Institutes of Health, HHS)
Dated: August 13, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-17744 Filed 8-17-21; 8:45 am]
BILLING CODE 4140-01-P
